Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
58.9M
-
Number of holders
-
176
-
Total 13F shares, excl. options
-
54.8M
-
Shares change
-
+306K
-
Total reported value, excl. options
-
$1.18B
-
Value change
-
+$10.4M
-
Put/Call ratio
-
0.91
-
Number of buys
-
81
-
Number of sells
-
-82
-
Price
-
$21.51
Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q2 2021
205 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q2 2021.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 176 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.8M shares
of 58.9M outstanding shares and own 93.06% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.87M shares), VANGUARD GROUP INC (4.1M shares), Palo Alto Investors LP (3.79M shares), RENAISSANCE TECHNOLOGIES LLC (3.31M shares), MACQUARIE GROUP LTD (3.2M shares), STATE STREET CORP (3.16M shares), ARMISTICE CAPITAL, LLC (2.71M shares), DIMENSIONAL FUND ADVISORS LP (1.97M shares), LSV ASSET MANAGEMENT (1.85M shares), and Epoch Investment Partners, Inc. (1.84M shares).
This table shows the top 176 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.